ProPhase Labs
PRPH
PRPH was delisted on the 2nd of January, 2026.
30 hedge funds and large institutions have $1.91M invested in ProPhase Labs in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
11% more funds holding
Funds holding: 27 → 30 (+3)
0.1% more ownership
Funds ownership: 0.92% → 1.01% (+0.1%)
55% less capital invested
Capital invested by funds: $4.23M → $1.91M (-$2.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSWM
Sheets Smith Wealth Management
Winston-Salem,
North Carolina
|
+$292K |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$150K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$143K |
| 4 |
Renaissance Technologies
New York
|
+$100K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$55.9K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$32K |
| 3 |
Barclays
London,
United Kingdom
|
-$28.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.2K |
PRPH Hedge Fund Activity: Q4 2024 in Review
30 of the 7,605 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q4 2024, worth a combined $1.91M — down 55% from $4.23M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PRPH positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Sheets Smith Wealth Management, opening a new position worth an estimated $292K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $55.9K sold.
- 30 institutional investors held ProPhase Labs (PRPH) as of Q4 2024, up from 27 in Q3 2024.
- Funds reported $1.91M of ProPhase Labs stock for Q4 2024, down 55% quarter-over-quarter.
- 8 funds opened new ProPhase Labs positions in Q4 2024 and 5 closed out, a net change of +3 holders.
- The largest ProPhase Labs buyer in Q4 2024 was Sheets Smith Wealth Management, an estimated $292K added.
- The largest ProPhase Labs seller in Q4 2024 was Bridgeway Capital Management, an estimated $55.9K sold.
Based on aggregated 13F filings for Q4 2024.